XFOR (X4 Pharmaceuticals) Inventory Turnover: 0.13 (As of Mar. 2026)

What is X4 Pharmaceuticals Inventory Turnover?

X4 Pharmaceuticals XFOR -2.44% 29 Inventory Turnover is 0.13 as of Mar. 2026. GuruFocus rates XFOR with a GF Score™ of 29/100. The stock has 6 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. X4 Pharmaceuticals's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.60 Mil. X4 Pharmaceuticals's Average Total Inventories for the quarter that ended in Mar. 2026 was $4.56 Mil. X4 Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.13.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. X4 Pharmaceuticals's Days Inventory for the three months ended in Mar. 2026 was 695.51.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. X4 Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 1.68.

X4 Pharmaceuticals (NAS:XFOR) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

X4 Pharmaceuticals's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	4.558	/	0.598	*	365 / 4
	=	695.51

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

X4 Pharmaceuticals's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	4.558	/	2.708
	=	1.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

X4 Pharmaceuticals Inventory Turnover Related Terms

X4 Pharmaceuticals Inventory Turnover Historical Data

* Premium members only.

The historical data trend for X4 Pharmaceuticals's Inventory Turnover can be seen below:

X4 Pharmaceuticals Inventory Turnover Chart

X4 Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

0.00

0.28

1.58

X4 Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															1.60	0.10	0.10	0.09	0.13

29GF Score

X4 Pharmaceuticals Inc XFOR

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

X4 Pharmaceuticals Inventory Turnover Calculation

X4 Pharmaceuticals's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	5.757	/ (	(2.817	+	4.479)	/	2 )
=	5.757	/	3.648
=	1.58

X4 Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	0.598	/ (	(4.479	+	4.637)	/	2 )
=	0.598	/	4.558
=	0.13

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.13 mean?

X4 Pharmaceuticals (XFOR) has a Inventory Turnover of 0.13 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on X4 Pharmaceuticals and its competitors.

Is X4 Pharmaceuticals' Inventory Turnover too high?

X4 Pharmaceuticals' current Inventory Turnover is 0.13. Overall, X4 Pharmaceuticals has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.

How does X4 Pharmaceuticals' Inventory Turnover compare to ZURA and LYEL?

X4 Pharmaceuticals' Inventory Turnover of 0.13 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Biotechnology company?

A good Inventory Turnover depends on the Biotechnology industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on X4 Pharmaceuticals and its competitors. X4 Pharmaceuticals's current Inventory Turnover is 0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is X4 Pharmaceuticals stock overvalued right now?

X4 Pharmaceuticals (XFOR) has a current Inventory Turnover of 0.13. The current Inventory Turnover is 0.13. X4 Pharmaceuticals' overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For X4 Pharmaceuticals (XFOR), the current Inventory Turnover is 0.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

X4 Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies ZURA LYEL LXEO CYDY BNTC OABI FBRX VNDA ARTV CMPX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 61 North Beacon Street, 4th Floor, Boston, MA, USA, 02134

Website https://www.x4pharma.com

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

29GF Score

Get the complete analysis for XFOR

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.01

Price

View XFOR Analysis

See Inventory Turnover data for all stocks →